spacer
home > ict > winter 2018 > dodging delays
PAY PER VIEW SERVICE

 

Dear guest!

article: Dodging Delays
format: Adobe Acrobat PDF file
cost: £

spacer

 
News and Press Releases

TransCure bioServices delivers CDX mouse models to advance AML preclinical studies

Archamps, 6 March 2023 TransCure bioServices has developed cell line-derived xenograft (CDX) mouse models that will change how researchers tackle the preclinical studies of cancer therapies to treat acute myeloid leukemia (AML). These models enable deeper insights into the efficacy and toxicity of AML therapies, leading to the development of better treatments and bringing hope to the thousands of patients that receive an AML diagnosis each year.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement